Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis …
HG Yebyo, HE Aschmann, M Kaufmann… - American heart journal, 2019 - Elsevier
Background The current guidelines of statins for primary cardiovascular disease (CVD)
prevention were based on results from systematic reviews and meta-analyses that suffer …
prevention were based on results from systematic reviews and meta-analyses that suffer …
Best–worst scaling and the prioritization of objects in health: a systematic review
Abstract Background and Objective Best–worst scaling is a theory-driven method that can be
used to prioritize objects in health. We sought to characterize all studies of best–worst …
used to prioritize objects in health. We sought to characterize all studies of best–worst …
Finding the balance between benefits and harms when using statins for primary prevention of cardiovascular disease: a modeling study
Background: Many guidelines use expected risk for cardiovascular disease (CVD) during
the next 10 years as a basis for recommendations on use of statins for primary prevention of …
the next 10 years as a basis for recommendations on use of statins for primary prevention of …
Prescribing pattern of statins for primary prevention of cardiovascular diseases in patients with type 2 diabetes: insights from Ethiopia
GT Demoz, S Wahdey, GG Kasahun, K Hagazy… - BMC research …, 2019 - Springer
Objective Although most clinical practice guidelines endorsed statin use in type 2 diabetes
(T2D) patients for reducing cardiovascular diseases (CVD), little is known about statin …
(T2D) patients for reducing cardiovascular diseases (CVD), little is known about statin …
Patient preference distribution for use of statin therapy
S Brodney, KD Valentine, K Sepucha… - JAMA Network …, 2021 - jamanetwork.com
Importance Thresholds for initiating statin therapy should be informed by patients'
preferences. Objective To define the preference distribution for statin therapy across the …
preferences. Objective To define the preference distribution for statin therapy across the …
GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit–harm modelling study
H Moll, E Frey, P Gerber, B Geidl, M Kaufmann… - …, 2024 - thelancet.com
Summary Background The benefit of Glucagon-like Peptide-1 (GLP-1) receptor agonists
(RAs) in weight reduction against potential harms remains unclear. This study aimed at …
(RAs) in weight reduction against potential harms remains unclear. This study aimed at …
Two decades of overuse and underuse of interventions for primary and secondary prevention of cardiovascular diseases: a systematic review
O Byambasuren, L Hattingh, M Jones… - Current Problems in …, 2023 - Elsevier
Quality use of anti-hypertensive and cholesterol-lowering medications is crucial for
successful cardiovascular disease management. This systematic review aimed to estimate …
successful cardiovascular disease management. This systematic review aimed to estimate …
Impact of outcome definitions on cardiovascular risk prediction in a contemporary primary prevention population
M Sud, A Chu, PC Austin, DM Naimark… - … Journal-Quality of …, 2023 - academic.oup.com
Background Estimation of an individual's cardiovascular disease (CVD) risk may enhance
risk discussion and treatment decisions. Yet, common cardiovascular outcomes such as …
risk discussion and treatment decisions. Yet, common cardiovascular outcomes such as …
Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scaling
HE Aschmann, MA Puhan, CW Robbins… - Health and quality of life …, 2019 - Springer
Background Older people with hypertension and multiple chronic conditions (MCC) receive
complex treatments and face challenging trade-offs. Patients' preferences for different health …
complex treatments and face challenging trade-offs. Patients' preferences for different health …
[HTML][HTML] Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention
Objective Personalizing preventive therapies for atherosclerotic cardiovascular disease
(ASCVD) is particularly important for older adults, as they tend to have multiple chronic …
(ASCVD) is particularly important for older adults, as they tend to have multiple chronic …